logo
Search…
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Search...
search
home
TOP News
Latest
RecommendHK StockUS StockChina StockMacroBond
Commercial
GlobalInvestment&FinancingCompany&ProductsCharacterESG
Economy&politics
Hong KongChinaAmerica
Stocks
HK StockChina StockUS Stock
Markets
HK StockUS Stock
IPO
Hong KongAmericaChina
Research
US StockHK Stock
Opinion
Recommendation
Home > Stocks > HK Stock

WANT WANT CHINA (00151) spent HK$6,959,500 on August 17 to repurchase 2.1 million shares.

date
17:59 17/08/2026
avatar
GMT Eight
China Wangwang (00151) announced that the company will spend HKD 6.9595 million to buy back 2.1 million shares on August 17, 2026, at a buyback price of HKD 3.26-3.34 per share.
WANT WANT CHINA (00151) announced that the company will spend HKD 6.9595 million to repurchase 2.1 million shares on August 17, 2026, at a repurchase price of HKD 3.26-3.34 per share.
Related Articles
US Stock Market Move | Argenx (ARGX.US) pre-market rose over 10% as its autoimmune myositis drug Vyvgart reached its primary endpoint in Phase III trials.
HK Stock
ARTINI HLDG-OLD(00789): Hu Xiaofan has been appointed as an independent non-executive director.
HK Stock
YESTAR HEALTH (02393) issued a profit warning, expecting a mid-term comprehensive net loss of no less than 450,000 yuan, turning from profit to loss year-on-year.
US Stock Market Move | Argenx (ARGX.US) pre-market rose over 10% as its autoimmune myositis drug Vyvgart reached its primary endpoint in Phase III trials.
ARTINI HLDG-OLD(00789): Hu Xiaofan has been appointed as an independent non-executive director.
HK Stock
YESTAR HEALTH (02393) issued a profit warning, expecting a mid-term comprehensive net loss of no less than 450,000 yuan, turning from profit to loss year-on-year.
HK Stock
RECOMMEND
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
Hot A‑Share Stocks Clarify Physical AI, Robotics, Aerospace, and Duty‑Free Themes Amid Frenzied Trading
icon
10/06/2026
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
U.S. AI Trading Frenzy Collapses as Jobs Data Fuels Fed Hike Fears
icon
10/06/2026
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
Goldman Sachs Warns of AI‑Driven Market Heat, But Bubble Indicators Still Below Historical Extremes
icon
10/06/2026
logo
Contact US
qr
+852 - 60190728
gmteight@futurecultural.com
Customer Support
About Us
Contact Us
Frequently Asked
Privacy Policy
Terms of Use
Commercial Services
Advertising
Business Development
Copyright
Terms of Service
©️2013 - 2026 GMT EIGHT Holdings. All Rights Reserved.